Contents
On this page
AcademySystematic Review
Reporting guidelinePRISMA-ScR 2018
PRISMA-ScR Checklist Explained Item by Item: Reporting a Scoping Review
What each of the 22 PRISMA-ScR items asks for, where it goes in the manuscript, how it compares with PRISMA 2020, and how to build a flow diagram whose numbers reconcile.
- Scoping review
- PRISMA-ScR
- Reporting guidelines
- Published
- 2018, Annals of Internal Medicine
- Items
- 22: 20 essential, 2 optional
- Optional items
- 12 and 16 (critical appraisal)
- Status
- 2018 version current; update in development
At a glanceSystematic Review
Explore reporting checklist reviewDiscuss your project
Quick answer
- PRISMA-ScR has 22 items: 20 essential and two optional critical appraisal items (12 and 16).
- It was adapted from PRISMA 2009: five items were removed and two made optional.
- Item 14 asks for selection numbers with exclusion reasons, “ideally using a flow diagram”; authors usually adapt the PRISMA 2020 template.
- Item 22 covers funding of the included sources as well as of the review itself.
What the PRISMA-ScR checklist is
The PRISMA-ScR checklist is the reporting guideline for scoping reviews. Published in 2018 as an extension of PRISMA, it contains 22 items: 20 essential items and two optional items on critical appraisal1. It tells authors what to report, not how to conduct the review; conduct guidance comes from sources such as the JBI methodology for scoping reviews2.
This guide explains every item using the official wording, shows where each item goes in the manuscript, gives illustrative example wording and lists the errors that most often weaken compliance. For the full method, from question to write-up, see our guide to how to write a scoping review.
Status as of November 2026: the 2018 checklist is still the current version. An update is in development: the update team has published its protocol and a scoping review that identified 37 candidate reporting items, which will be assessed in a Delphi survey34. Check the EQUATOR Network listing before submission in case the updated guideline has been released.
How PRISMA-ScR differs from PRISMA
PRISMA-ScR was adapted from the original PRISMA statement of 2009, not from PRISMA 2020. Of the 27 PRISMA 2009 items, five were removed as not relevant to scoping reviews and two were made optional1. The removed items cover summary measures, risk of bias across studies and additional analyses; the two risk-of-bias items for individual studies became optional critical appraisal items 12 and 16.
The terminology also changes. Because scoping reviews can include any type of evidence, PRISMA-ScR uses “sources of evidence” instead of “studies”, “data charting” instead of “data extraction”, and “critical appraisal” instead of “risk of bias”12.
PRISMA 2020 has since replaced PRISMA 2009 for systematic reviews5. Many authors therefore meet PRISMA 2020 conventions, such as its flow diagram, alongside a checklist built on the older structure. Table 1 shows how the two compare today.
Table 1. PRISMA-ScR (2018) compared with PRISMA 2020.
| Feature | PRISMA-ScR 2018 | PRISMA 2020 |
|---|---|---|
| Origin | Adapted from PRISMA 2009 (27 items) | Update of PRISMA 2009 |
| Number of items | 22: 20 essential, 2 optional | 27, several with sub-items |
| Unit of analysis | Sources of evidence (any type, including grey literature and policy documents) | Studies and reports |
| Data collection | Data charting | Data collection process |
| Quality assessment | Optional critical appraisal (items 12 and 16) | Risk of bias in individual studies (required) |
| Effect measures, meta-analysis, reporting bias, certainty of evidence | Not included | Required where relevant |
| Registration and protocol | Item 5: protocol and registration details | Items 24a–c, including protocol amendments |
| Competing interests; data, code and materials | No dedicated items | Items 26 and 27 |
| Flow diagram | Item 14, “ideally” a flow diagram; no dedicated template | Templates for new and updated reviews |
Where PRISMA-ScR has no item, such as competing interests or data availability, check the journal’s instructions, which may require these statements regardless of review type.
The 22 PRISMA-ScR items
Table 2 lists each item with a summary of the official wording, the manuscript section where it usually sits, illustrative example wording from a fictional review of digital medication management in older adults, and a common error1. Confirm the exact wording against the official checklist when you complete it.
Table 2. The 22 PRISMA-ScR items, with manuscript section, illustrative example wording (fictional review) and common errors.
| No. | Item | What to report | Manuscript section | Example wording (illustrative) | Common error |
|---|---|---|---|---|---|
| 1 | Title | Identify the report as a scoping review | Title | “Digital medication management for older adults with multimorbidity: a scoping review” | “Systematic review” or “literature review” in the title |
| 2 | Structured summary | Background, objectives, eligibility criteria, sources of evidence, charting methods, results and conclusions, as applicable | Abstract | Structured abstract that states the PCC elements and the number of included sources | Abstract reports effectiveness conclusions the methods cannot support |
| 3 | Rationale | What is already known, and why the questions suit a scoping approach | Introduction | “Interventions and outcomes in this field have not been mapped…” | No explanation of why a scoping rather than systematic review was chosen |
| 4 | Objectives | Explicit questions and objectives with their key elements (e.g. population, concept, context) | Introduction | “To map the digital interventions, settings and outcomes reported…” | Objectives phrased as effectiveness questions |
| 5 | Protocol and registration | Whether a protocol exists, where it can be accessed and, if registered, the registration number | Methods | “The protocol was registered on OSF Registries (DOI: 10.17605/OSF.IO/ABCDE, fictional)” | Protocol not mentioned, or deviations from it not explained |
| 6 | Eligibility criteria | Characteristics of sources used as eligibility criteria (e.g. years, language, publication status), with a rationale | Methods | PCC criteria plus source types, languages and date limits, each justified | Language or date limits stated without a reason |
| 7 | Information sources | All information sources (e.g. databases with dates of coverage, contact with authors to identify additional sources) and the date of the most recent search | Methods | “MEDLINE (Ovid, 1946 to present), Embase (Elsevier, 1974 to present) and CINAHL (EBSCOhost, 1981 to present); last searched 12 May 2026; experts contacted for further sources” (confirm coverage dates for your own platform and subscription) | Database coverage dates or the final search date missing |
| 8 | Search | Full electronic search strategy for at least one database, including limits, so it could be repeated | Methods and supplement | Complete MEDLINE strategy, with line numbers, in a supplementary file | Keywords listed instead of the full strategy |
| 9 | Selection of sources of evidence | Process for selecting sources (screening and eligibility) | Methods | “Two reviewers screened titles, abstracts and full texts independently after a pilot round…” | Number of reviewers and conflict resolution not stated |
| 10 | Data charting process | Methods of charting data (e.g. calibrated or pilot-tested forms, independent or duplicate charting) and any processes for obtaining and confirming data from investigators | Methods | “The form was piloted on five sources; one reviewer charted and a second verified; authors were emailed to confirm unclear details” | No mention of piloting, duplication or contact with investigators |
| 11 | Data items | All variables sought, defined, with any assumptions and simplifications | Methods | Defined list of charting variables in a table or supplement | Variables charted that do not relate to the questions |
| 12 | Critical appraisal (optional) | If done, the rationale, methods and how results were used in any synthesis | Methods | “Critical appraisal was not undertaken, in line with the review’s mapping objective” | Silent omission, or appraisal used to exclude sources without justification |
| 13 | Synthesis of results | Methods of handling and summarising charted data | Methods | “Frequency counts and basic qualitative content analysis…” | Synthesis method not described |
| 14 | Selection of sources of evidence | Numbers screened, assessed for eligibility and included, with reasons for exclusion at each stage, ideally using a flow diagram | Results | Adapted PRISMA 2020 flow diagram | Numbers that do not reconcile, or full-text exclusions without reasons |
| 15 | Characteristics of sources of evidence | For each source, the characteristics charted, with citations | Results | Table of included sources with citations | Characteristics given only in aggregate |
| 16 | Critical appraisal within sources (optional) | If done, appraisal data for included sources | Results | Appraisal table, or a statement that item 12 was not done | Appraisal described in methods but results not presented |
| 17 | Results of individual sources | For each source, the charted data relevant to the questions and objectives | Results or supplement | Full charting table as a supplementary file | Only selected sources shown |
| 18 | Synthesis of results | Summary and/or presentation of charting results as they relate to the questions and objectives | Results | Evidence map of interventions against outcomes, with narrative | Charts with no link to the review questions |
| 19 | Summary of evidence | Main results (including an overview of concepts, themes and types of evidence available), link to the questions and objectives, and relevance to key groups | Discussion | “Quality of life was measured in only a minority of sources, which matters for commissioners…” | Claims about whether interventions work |
| 20 | Limitations | Limitations of the scoping review process | Discussion | Languages the team could not translate were excluded; grey literature searched only on selected websites | Limitations of the included studies only, not of the review process |
| 21 | Conclusions | General interpretation with respect to the questions and objectives, potential implications and/or next steps | Discussion | Research gaps and priorities for primary studies or systematic reviews | Practice recommendations not supported by a mapping review |
| 22 | Funding | Funding of the included sources of evidence and of the scoping review, and the role of the review’s funders | Funding statement | Review funder and its role; industry funding of included sources charted | Funding of included sources not reported |
The methods carry the heaviest reporting load. Table 3 shows how the 22 items are distributed across manuscript sections.
Table 3. Distribution of PRISMA-ScR items by manuscript section.
| Section | Items | Number of items |
|---|---|---|
| Title | 1 | 1 |
| Abstract | 2 | 1 |
| Introduction | 3–4 | 2 |
| Methods | 5–13 (item 12 optional) | 9 |
| Results | 14–18 (item 16 optional) | 5 |
| Discussion | 19–21 | 3 |
| Funding | 22 | 1 |
| Total | 22 |
Check your scoping review against PRISMA-ScR before submission
Pubrica’s reporting checklist review goes through your manuscript item by item against PRISMA-ScR and JBI guidance, checks that flow-diagram numbers reconcile and that search and charting methods are reported in full, and returns a marked-up checklist with suggested fixes. Authors keep ownership of and accountability for the review, and no provider can guarantee acceptance.
Items that need the most care
Items 7 and 8 (sources and search). Item 7 asks for every information source with dates of coverage, any contact with authors to find more sources, and the date of the most recent search. Item 8 asks for the full strategy for at least one database, including limits, so that it could be repeated1. PRISMA-S gives more detail on reporting searches, including platforms, registries, citation searching and deduplication6; our PRISMA-S checklist guide explains each item, and our grey literature guide covers non-database sources.
Item 10 (data charting). Report how the charting form was developed and calibrated, whether charting was done independently or in duplicate, and how data were obtained or confirmed from investigators1. JBI recommends charting only data that answer the review questions7.
Items 12 and 16 (critical appraisal). Both are optional. JBI guidance notes that appraisal is generally not performed in scoping reviews2. If you do appraise, give the rationale and method and explain how results were used. A one-sentence statement either way prevents a reviewer query.
Item 14 (selection of sources). Report numbers screened, assessed and included, with reasons for exclusion at each stage, “ideally using a flow diagram”1. The diagram is recommended rather than mandatory, but including one is good practice and makes the numbers easier to check.
Item 19 (summary of evidence). Summarise the main results, including the concepts, themes and types of evidence available, link them to the questions and consider their relevance to key groups such as patients, clinicians or policymakers1.
Item 22 (funding). Report the funding of the included sources of evidence as well as the funding of the review itself, and the role of the review’s funders1. Add funder type to the charting form at the start so this item is not left until the end.
Common gaps in published scoping reviews
Common gaps in published scoping reviews include missing protocols and a lack of duplicate screening and charting. A 2016 analysis of 494 scoping reviews published between 1999 and 2014, before PRISMA-ScR existed, found that only 13% reported using a protocol and 30% used two reviewers for data charting8. More recently, the PRISMA-ScR update team drew on studies of reporting completeness and guidance documents to propose 37 candidate items, including reporting protocol deviations and stating inclusion criteria with a framework such as PCC3. Table 4 lists gaps to check and how to fix them.
Table 4. Reporting gaps to check before submission, with fixes.
| Item | Gap | Fix |
|---|---|---|
| 5 Protocol | No protocol, or a scoping review submitted to PROSPERO, which does not accept scoping reviews9 | Register on OSF Registries or INPLASY, or cite a published protocol, and report deviations |
| 7 Information sources | Coverage dates, author contact or the final search date missing | List every source with platform, coverage and the date of the most recent search |
| 8 Search | Only search terms listed | Provide the complete strategy for at least one database, including limits |
| 10 Data charting | No piloting, single-reviewer charting not acknowledged, no contact with investigators | Describe form development, calibration, who charted and verified, and data confirmation |
| 12/16 Appraisal | Silently omitted | State whether appraisal was done; if done, justify it and do not use it to exclude sources |
| 14 Selection | Totals that do not reconcile; grey literature merged with database records | Use the PRISMA 2020 layout with a separate column for other methods |
| 19 Summary | Effectiveness claims from mapped evidence | Describe what evidence exists, its types and gaps, not whether interventions work |
| 22 Funding | Funding of included sources not charted | Chart funder type for each source and report it with the review’s own funding |
The PRISMA-ScR flow diagram
There is no separate PRISMA-ScR flow diagram template. Authors usually adapt the PRISMA 2020 template, which has a column for databases and registers and a second column for other methods such as websites, organisations and citation searching5. Replace “studies” with “sources of evidence” in the final box, and check whether the PRISMA-ScR update introduces its own template3. Our PRISMA 2020 flow diagram guide explains each box.
Worked example (illustrative numbers, fictional review). Table 5 shows reconciled counts, with grey literature and reference-list sources kept separate from database records.
Table 5. Illustrative flow-diagram counts for a fictional scoping review, with separate columns for databases and other methods.
| Stage | Databases | Other methods |
|---|---|---|
| Records identified | 1,311 (MEDLINE 512; Embase 604; CINAHL 195) | 35 new records (websites 24; citation searching 11)* |
| Records removed before screening (duplicates) | 312 | No box in the template* |
| Records screened (title and abstract) | 999 | Not applicable (assessed directly at full text) |
| Records excluded | 861 | Not applicable |
| Reports sought for retrieval | 138 | 35 |
| Reports not retrieved | 2 | 1 |
| Reports assessed for eligibility | 136 | 34 |
| Reports excluded, with reasons | 98 (population 41; concept 37; context 9; conference abstract only 11) | 30 (concept 22; population 8) |
| Sources of evidence included | 38 | 4 |
| Total included in the review | 42 |
Check the arithmetic at every stage. Databases: 1,311 − 312 = 999 screened; 999 − 861 = 138 sought; 138 − 2 = 136 assessed; 136 − 98 = 38 included. Other methods: 35 sought; 35 − 1 = 34 assessed; 34 − 30 = 4 included. Total: 38 + 4 = 42 sources of evidence. Exclusion reasons add up to each exclusion total (41 + 37 + 9 + 11 = 98; 22 + 8 = 30).
*PRISMA 2020’s other-methods column has no duplicates box; report records already found by the database search in the text or a footnote, or show them as excluded at retrieval5. In this example, citation searching found 15 records, 4 of which the database search had already identified; the footnote reports these 4, and only the 35 new records enter the column.
Reconciliation checks
Records identified minus all records removed before screening (duplicates, records marked ineligible by automation tools, and other reasons) must equal records screened5. Each exclusion box must list reasons that sum to its total. Numbers in the abstract, results text and diagram must match. If one report describes several sources, or one source has several reports, say which you counted.
Using the protocol to prepare PRISMA-ScR reporting
Writing the protocol with the final report in mind makes PRISMA-ScR reporting easier. For scoping reviews, use the JBI guidance and reporting items for scoping review protocols10. PRISMA-P was designed for systematic review protocols11, so use it only if a journal asks.
A good protocol pre-specifies the objectives, eligibility criteria, sources, search, selection and charting methods, which map onto PRISMA-ScR items 4 to 13. Register it on OSF Registries, which offers a generalised form suitable for scoping reviews12, or INPLASY (fee-based, with a scoping review form; check the current fee)13, or publish it in a journal; PROSPERO does not accept scoping reviews9. Our comparison of PROSPERO, OSF and INPLASY explains the options, and our illustrative case studies show how review teams handle protocols in practice. For quick answers, see our scoping review Q&A.
PRISMA-ScR pre-submission check
- The title includes the words “scoping review”.
- Protocol location and registration number are given, with any deviations explained.
- Every information source has coverage dates, and the date of the most recent search is stated.
- The full search strategy for at least one database, with limits, is in a supplement.
- Charting methods describe piloting, independent or duplicate charting, and contact with investigators.
- A clear statement says whether critical appraisal was done.
- Flow-diagram numbers reconcile, with other methods shown separately.
- The discussion maps evidence and gaps without claiming effectiveness.
- Funding of included sources and of the review, and the funder’s role, are reported.
- The completed checklist gives a page or section reference for every item.
Conclusion
The PRISMA-ScR checklist turns a scoping review into a transparent, reproducible report. Address all 20 essential items, state what you did about the two optional appraisal items, give a reconciled selection flow (ideally as a diagram), and describe the evidence map without implying effectiveness. Until the update is published, the 2018 checklist remains the standard to cite13.
Pubrica team verdict
If a reader cannot see which sources you searched, how you charted data, how many sources you included and why, and who funded the evidence and the review, the report is not yet PRISMA-ScR compliant.
Frequently asked questions
Sources
Sources were checked on 22 November 2026. Requirements and guidance may change after that date; confirm the current version with the issuing body.
- 1Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467-73. https://doi.org/10.7326/M18-0850
- 2Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119-26. https://doi.org/10.11124/JBIES-20-00167
- 3Tricco AC, Robinson E, Straus SE, Colquhoun H, Godfrey CM, Moher D, et al. Updating the PRISMA reporting guideline for scoping reviews: a scoping review. J Clin Epidemiol. 2026;196:112314. https://doi.org/10.1016/j.jclinepi.2026.112314
- 4Veroniki AA, Hutton B, Stevens A, McKenzie JE, Page MJ, Moher D, et al. Update to the PRISMA guidelines for network meta-analyses and scoping reviews and development of guidelines for rapid reviews: a scoping review protocol. JBI Evid Synth. 2025;23(3):517-26. https://doi.org/10.11124/JBIES-24-00308
- 5Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71
- 6Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, et al. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Syst Rev. 2021;10(1):39. https://doi.org/10.1186/s13643-020-01542-z
- 7Pollock D, Peters MDJ, Khalil H, McInerney P, Alexander L, Tricco AC, et al. Recommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evid Synth. 2023;21(3):520-32. https://doi.org/10.11124/JBIES-22-00123
- 8Tricco AC, Lillie E, Zarin W, O’Brien K, Colquhoun H, Kastner M, et al. A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol. 2016;16:15. https://doi.org/10.1186/s12874-016-0116-4
- 9Centre for Reviews and Dissemination. PROSPERO [Internet]. York: University of York; [cited 2026 Nov 22]. https://www.crd.york.ac.uk/prospero/
- 10Peters MDJ, Godfrey C, McInerney P, Khalil H, Larsen P, Marnie C, et al. Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth. 2022;20(4):953-68. https://doi.org/10.11124/JBIES-21-00242
- 11Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. https://doi.org/10.1186/2046-4053-4-1
- 12van den Akker OR, Peters GY, Bakker CJ, Carlsson R, Coles NA, Corker KS, et al. Increasing the transparency of systematic reviews: presenting a generalized registration form. Syst Rev. 2023;12(1):170. https://doi.org/10.1186/s13643-023-02281-7
- 13Canellas JVDS, Ritto FG, Rodolico A, Aguglia E, Fernandes GVO, Figueredo CMDS, et al. The international platform of registered systematic review and meta-analysis protocols (INPLASY) at 3 years: an analysis of 4,658 registered protocols on inplasy.com, platform features, and website statistics. Front Res Metr Anal. 2023;8:1135853. https://doi.org/10.3389/frma.2023.1135853
PRISMA-ScR checklistscoping reviewreporting guidelinedata chartingsources of evidencecritical appraisal
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation, so check its guide if it has one.
Dr. Charlie. (2026, November 22). PRISMA-ScR Checklist Explained Item by Item: Reporting a Scoping Review. Pubrica. https://pubrica.com/academy/systematic-review/prisma-scr-checklist/
This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Next steps
Check your scoping review against PRISMA-ScR before submission
Pubrica’s reporting checklist review goes through your manuscript item by item against PRISMA-ScR and JBI guidance, checks that flow-diagram numbers reconcile and that search and charting methods are reported in full, and returns a marked-up checklist with suggested fixes. Authors keep ownership of and accountability for the review, and no provider can guarantee acceptance.
This article is general information for researchers, not legal, regulatory or funding advice. Check the current requirements of your journal, funder, ethics committee or regulator before you act on it.
More in Systematic Review